Kiromic Biopharma Inc (KRBP) — Tangible Net Worth Ratio
Kiromic Biopharma Inc (KRBP) has a Tangible Net Worth Ratio of 100.0% as of September 2022. This metric is calculated by deducting intangible assets ($0.00) from net assets ($284.10K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Kiromic Biopharma Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Kiromic Biopharma Inc Tangible Net Worth Ratio (2018–2021)
This chart shows how Kiromic Biopharma Inc's Tangible Net Worth Ratio has changed across 4 annual periods from 2018 to 2021. As of September 2022, the ratio stands at 100.0%, reflecting net assets of $284.10K with intangible assets of $0.00 USD. See Kiromic Biopharma Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Kiromic Biopharma Inc (2018–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for Kiromic Biopharma Inc from 2018 to 2021, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Kiromic Biopharma Inc (KRBP) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $27.32 Million | $0.00 | $30.73 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $11.36 Million | $0.00 | $12.83 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $1.98 Million | $0.00 | $2.65 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $265.30K | $0.00 | $876.00K | — |